|
|
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2042-2049.
Prepublished online as a Blood First Edition Paper on June 7, 2005; DOI 10.1182/blood-2005-01-0186.
Previous Article | Next Article 
Submitted January 14, 2005
Accepted May 18, 2005
Expression of 11 -hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells
Lisa Freeman, Martin Hewison, Susan V Hughes, Katie N Evans, Deborah Hardie, Terry K Means, and Ronjon Chakraverty*
Department of Hematology, University of Birmingham, Birmingham, United Kingdom
Department of Medical Sciences, University of Birmingham, Birmingham, United Kingdom
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA, USA
* Corresponding author; email: r.chakraverty{at}medsch.ucl.ac.uk.
Glucocorticoids (GC) exert powerful anti-inflammatory effects that may relate in part to their ability to restrict the differentiation and function of dendritic cells (DCs). Although these inhibitory effects are dependent upon GC binding to nuclear glucocorticoid receptors (GR), fine tuning of GR signalling is achieved by pre-receptor inter-conversion of cortisol that binds GR with high affinity and cortisone that does not. We show for the first time that human monocyte-derived DCs are able to generate cortisol as a consequence of up-regulated expression of the enzyme, 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD1). Immature DCs demonstrate selective enhancement of 11 -HSD1 reductase activity leading to increased conversion of inactive cortisone to active cortisol. Enhancement of GC bioavailability is maintained or increased upon terminal differentiation induced by signals associated with innate immune activation. In marked contrast, maturation induced by CD40 ligation leads to a sharp reduction in cortisol generation by DC. The differentiation of DCs from monocyte precursors is inhibited at physiological concentrations of inactive cortisone, an effect that requires activity of the 11 -HSD1 enzyme. In conclusion, pre-receptor regulation of endogenous GC appears to be an important determinant of DC function and represents a potential target for therapeutic manipulation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
CD40 brings the shuttle down
- Cees van Kooten and Andrea M. Woltman
Blood 2005 106: 1895-1896.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. Hu, S. Fatma, J. Cao, J. S. Grunstein, G. Nino, Y. Grumbach, and M. M. Grunstein
Th2 cytokine-induced upregulation of 11{beta}-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function
Am J Physiol Lung Cell Mol Physiol,
May 1, 2009;
296(5):
L790 - L803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D'Elia, J. Patenaude, and J. Bernier
Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice
Am J Physiol Endocrinol Metab,
January 1, 2009;
296(1):
E97 - E104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mascanfroni, M. d. M. Montesinos, S. Susperreguy, L. Cervi, J. M. Ilarregui, V. D. Ramseyer, A. M. Masini-Repiso, H. M. Targovnik, G. A. Rabinovich, and C. G. Pellizas
Control of dendritic cell maturation and function by triiodothyronine
FASEB J,
April 1, 2008;
22(4):
1032 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Vagnerova, M Kverka, P Klusonova, P Ergang, I Miksik, H Tlaskalova-Hogenova, and J Pacha
Intestinal inflammation modulates expression of 11{beta}-hydroxysteroid dehydrogenase in murine gut.
J. Endocrinol.,
November 1, 2006;
191(2):
497 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. U Onyimba, N. Vijapurapu, S J. Curnow, P. Khosla, P. M Stewart, P. I Murray, E. A Walker, and S. Rauz
Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
J. Endocrinol.,
August 1, 2006;
190(2):
483 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, G. Bonanno, A. Procoli, A. Mariotti, D. G. de Ritis, A. Curti, S. Danese, G. Pessina, S. Pandolfi, F. Natoni, et al.
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features
Blood,
July 1, 2006;
108(1):
218 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|